Transcript CDS Rules and CQM for Classic MU2

CDS Rules and CQM
for Classic MU2
Tips and discussion related to
building Clinical Decision
Support Rules for MU2
Please reference the accompanying Webinar located at
https://healthland.webex.com/healthland/lsr.php?
RCID=707e6d5949d144668c6eeca6aafdb9e6
A Tour Through Central Station
7/6/2015
CONFIDENTIAL |
2
7/6/2015
CONFIDENTIAL |
3
7/6/2015
CONFIDENTIAL |
4
Upcoming Educational Opportunities
• Virtual - Meaningful Use Stage 2 Best Practices Friday June
6th at 1pm – Includes Meaningful Use Manager Dash Board
view and CCDA – This class is 2 hours
• Virtual - Classic Eligible Hospital – Meaningful Use Stage 2
Core Set Measures Offered 3 separate times: Tuesday June
17th at 10am, June 19th at 10am and June 25th at 10am.
This class is 3 hours
• Virtual – Classic Eligible Hospital Meaningful Use Stage 2 Menu
Set and Clinical Quality Measures: Tuesday June 24th at
10am, Thursday June 26th at 10am and Monday, June
30th. This class is 3 hours
• Register on Central Station. If class is not listed, email
[email protected] or
• Reminder: This schedule may change without notice. Always
check Central Station for the most accurate information
7/6/2015
CONFIDENTIAL |
5
Core Measure #5 Clinical
Decision Support
(1) Implement 5 clinical decision support
interventions related to 4 or more clinical
quality measures at a relevant point in patient
care for the entire EHR reporting period.
6
Core Measure #5 Clinical
Decision Support
Absent four clinical quality measures related
to EH or CAH patient population, CDS
interventions must be related to high-priority
health conditions. It is suggested that one of
the 5 CDS interventions be related to
improving healthcare efficiency
7
Core Measure #5 Clinical
Decision Support Part 2
(2) The eligible hospital or CAH has enabled
the functionality for drug-drug and drugallergy interaction checks for the entire EHR
reporting period
8
Comparison to Stage 1
• Increased number of Clinical Decision Support rules
from 1 to 5
• Added Drug-Drug and Drug-Allergy criteria to this
measure
• Continues to be Self-Attestation
• No third party software required (However, if utilizing
Problem List, would utilize SNOMED-CT codes for
previous/current medical history)
7/6/2015
CONFIDENTIAL |
9
Tips for creating 5 CDS rules for MU2
• All 5 Clinical Decision Support rules should be active for
the ENTIRE reporting period
• Take a screen shot of the CDS rule when created and
activated. Retain to attach/upload for the Attestation
process
• Screen Shots can be attached to the Meaningful Use
Manager Dashboard
7/6/2015
CONFIDENTIAL |
10
16 CQM’s Supported by Healthland
• ED1 – Median Time from ED Arrival to ED Departure for Admitted ED
Patients
• ED2 – Median Admit Decision Time to ED Departure Time for Admitted
Patients
• ED3 – Median Time from ED Arrival to ED Departure for Discharged ED
Patients *New*
• Stroke2 – Discharged on Antithrombotic Therapy
• Stroke3 – Anticoagulation Therapy for Atrial Fibrillation/Flutter
• Stroke4 – Thrombolytic Therapy
• Stroke5 – Antithrombotic Therapy by End of Hospital Day 2
• Stroke6 – Discharged on Statin Medication
• Stroke8 – Stroke Education
• Stroke10 – Assessed for Rehabilitation
7/6/2015
CONFIDENTIAL |
11
16 CQM’s Support by Healthland
•
•
•
•
VTE1 – VTE Prophylaxis
VTE2 – Intensive Care Unit VTE Prophylaxis
VTE3 – VTE Patients with Anticoagulant Overlap Therapy
VTE4 – VTE Patients Receiving Unfractionated Heparin with
Dosages/Platelet Count Monitoring by Protocol
• VTE5 – VTE Discharge Instruction
• VTE6 – Incidence of Potential Preventable VTE
7/6/2015
CONFIDENTIAL |
12
Clinical Decision Support Set-Up
• Set-Up #1 – CDS rules based on or more of the
following variables: Problem List, Medication List,
Medication Allergy List, Demographics, Lab Results, Vital
Signs, Department Orders
• Go to IS Administration>Maintenance>Rules Alert
Maintenance>New
• Variables:
•
Demographics
•
Medications
•
Allergies
•
Lab results
•
Diagnosis (Problem List)
•
Med Allergies
•
Vital Signs
7/6/2015
CONFIDENTIAL |
13
Clinical Decision Support Set-Up
• Set-up #2 – Turn on Drug to Drug and Drug to Allergy
Interaction Checking
•
Go to Pharmacy Maintenance>Setup Maintenance>MediSpan
Settings tab
•
Perform Drug to Drug Interaction Checking field, Set to Y
•
Perform Drug to Allergy Interaction Checking field, Set to Y
•
In the Allergy Severity Filter field, select the desired setting for
severity This setting must be set to moderate or higher. Default is
set to Major
Additional items of note:
•
Ensure that users have the appropriate user permissions in IS
Administration>Maintenance>User Security Maintenance
•
Previously built CDS rules utilizing ICD-9 codes should be
converted to SNOMED-CT codes as the problem list will be
utilizing SNOMED-CT
7/6/2015
CONFIDENTIAL |
14
7/6/2015
CONFIDENTIAL |
15
7/6/2015
CONFIDENTIAL |
16
User Guide is your friend!
• Healthland Classic Meaningful Use Stage 2 User Guide is
your guide to:
1. Measure Definition
2. Details of how we are capturing the Numerator and Denominator
3. Exclusions (if any)
4. Module and Data Elements Used in the software to capture
information/data
5. Set Up Required
6. Comparison to Stage 1
7. 3rd Party Software required
8. Trouble shooting/Tips and Notes
Monitor for Updates to the Guide
7/6/2015
CONFIDENTIAL |
17
Questions?